Reference number : 236-2011-2012-Q2-00272, amendment number : , agreement type : G, recipient legal name : LAVASANIFAR, Afsaneh, recipient country : CA, recipient province : AB, recipient city : Edmonton, recipient postal code : T6G 2E1, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 100000.0, agreement start date : 2011-10-01, agreement end date : 2012-09-30, description english : Nano-delivery systems for cancer immunotherapy: Modulation of the anticancer immunity at the induction and effector phases, description french : Nano-delivery systems for cancer immunotherapy: Modulation of the anticancer immunity at the induction and effector phases, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2011-12 to 2012-13), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2011-12 à 2012-13), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada